FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2624340764> ?p ?o ?g. }

• W2624340764 endingPage "189" @default.
• W2624340764 startingPage "181" @default.
• W2624340764 abstract "To compare the outcomes of adjuvant chemotherapy (AC) versus observation in patients with non-organ confined disease after neoadjuvant chemotherapy and radical cystectomy (RC).Using the National Cancer Database, we identified patients who received NAC prior to RC and had advanced stage (pT3/4) or pathologically involved nodes (pN+) at the time of surgery from 2004-2013. We determined whether patients then received AC or were managed with observation only and used multivariable proportional hazards regression to estimate the impact of AC on overall survival.Overall 34% (N = 705) of patients who received NAC and underwent RC were pT3/4 and/or pN+. Of these patients, 24% (N = 168) received subsequent chemotherapy and the rest were observed. Median survival for the entire cohort was 21 months (IQR 12-45). There was not a statistically significant difference in median survival between the AC and observation groups (23 months [IQR 14-46] versus 20 months [IQR 12-46], log-rank p = 0.52). On multivariate analysis there was no survival advantage for the AC cohort. Subgroup analysis of pN+ patients who received AC also did not show a survival advantage.Patients who are pT3/4 and/or pN+ after NAC and RC have a poor prognosis. The addition of AC does not seem to be beneficial. Further research should focus identifying patients who may benefit from additional chemotherapy." @default.
• W2624340764 created "2017-06-15" @default.
• W2624340764 creator A5017881895 @default.
• W2624340764 creator A5021851942 @default.
• W2624340764 creator A5056273697 @default.
• W2624340764 creator A5056816160 @default.
• W2624340764 creator A5060409090 @default.
• W2624340764 date "2017-07-27" @default.
• W2624340764 modified "2023-10-16" @default.
• W2624340764 title "Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy" @default.
• W2624340764 cites W1604908658 @default.
• W2624340764 cites W1923922380 @default.
• W2624340764 cites W1971208896 @default.
• W2624340764 cites W1971903914 @default.
• W2624340764 cites W1975918912 @default.
• W2624340764 cites W1983950941 @default.
• W2624340764 cites W1984041346 @default.
• W2624340764 cites W1998421334 @default.
• W2624340764 cites W2033903194 @default.
• W2624340764 cites W2058833787 @default.
• W2624340764 cites W2062708843 @default.
• W2624340764 cites W2072065123 @default.
• W2624340764 cites W2073175347 @default.
• W2624340764 cites W2083397917 @default.
• W2624340764 cites W2120955645 @default.
• W2624340764 cites W2122254459 @default.
• W2624340764 cites W2126069168 @default.
• W2624340764 cites W2137616140 @default.
• W2624340764 cites W2146684961 @default.
• W2624340764 cites W2151278059 @default.
• W2624340764 cites W2161167127 @default.
• W2624340764 cites W2168846224 @default.
• W2624340764 cites W2308167615 @default.
• W2624340764 cites W2335976680 @default.
• W2624340764 cites W2470654889 @default.
• W2624340764 cites W2589769928 @default.
• W2624340764 cites W4231150365 @default.
• W2624340764 cites W4376546343 @default.
• W2624340764 cites W4382630031 @default.
• W2624340764 doi "https://doi.org/10.3233/blc-170107" @default.
• W2624340764 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5545911" @default.
• W2624340764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28824946" @default.
• W2624340764 hasPublicationYear "2017" @default.
• W2624340764 type Work @default.
• W2624340764 sameAs 2624340764 @default.
• W2624340764 citedByCount "14" @default.
• W2624340764 countsByYear W26243407642018 @default.
• W2624340764 countsByYear W26243407642019 @default.
• W2624340764 countsByYear W26243407642020 @default.
• W2624340764 countsByYear W26243407642021 @default.
• W2624340764 countsByYear W26243407642022 @default.
• W2624340764 crossrefType "journal-article" @default.
• W2624340764 hasAuthorship W2624340764A5017881895 @default.
• W2624340764 hasAuthorship W2624340764A5021851942 @default.
• W2624340764 hasAuthorship W2624340764A5056273697 @default.
• W2624340764 hasAuthorship W2624340764A5056816160 @default.
• W2624340764 hasAuthorship W2624340764A5060409090 @default.
• W2624340764 hasBestOaLocation W26243407641 @default.
• W2624340764 hasConcept C10515644 @default.
• W2624340764 hasConcept C121608353 @default.
• W2624340764 hasConcept C126322002 @default.
• W2624340764 hasConcept C126894567 @default.
• W2624340764 hasConcept C141071460 @default.
• W2624340764 hasConcept C143998085 @default.
• W2624340764 hasConcept C146357865 @default.
• W2624340764 hasConcept C151730666 @default.
• W2624340764 hasConcept C2775910329 @default.
• W2624340764 hasConcept C2776694085 @default.
• W2624340764 hasConcept C2777863537 @default.
• W2624340764 hasConcept C2780352672 @default.
• W2624340764 hasConcept C38180746 @default.
• W2624340764 hasConcept C50382708 @default.
• W2624340764 hasConcept C71924100 @default.
• W2624340764 hasConcept C72563966 @default.
• W2624340764 hasConcept C86803240 @default.
• W2624340764 hasConceptScore W2624340764C10515644 @default.
• W2624340764 hasConceptScore W2624340764C121608353 @default.
• W2624340764 hasConceptScore W2624340764C126322002 @default.
• W2624340764 hasConceptScore W2624340764C126894567 @default.
• W2624340764 hasConceptScore W2624340764C141071460 @default.
• W2624340764 hasConceptScore W2624340764C143998085 @default.
• W2624340764 hasConceptScore W2624340764C146357865 @default.
• W2624340764 hasConceptScore W2624340764C151730666 @default.
• W2624340764 hasConceptScore W2624340764C2775910329 @default.
• W2624340764 hasConceptScore W2624340764C2776694085 @default.
• W2624340764 hasConceptScore W2624340764C2777863537 @default.
• W2624340764 hasConceptScore W2624340764C2780352672 @default.
• W2624340764 hasConceptScore W2624340764C38180746 @default.
• W2624340764 hasConceptScore W2624340764C50382708 @default.
• W2624340764 hasConceptScore W2624340764C71924100 @default.
• W2624340764 hasConceptScore W2624340764C72563966 @default.
• W2624340764 hasConceptScore W2624340764C86803240 @default.
• W2624340764 hasIssue "3" @default.
• W2624340764 hasLocation W26243407641 @default.
• W2624340764 hasLocation W26243407642 @default.
• W2624340764 hasLocation W26243407643 @default.
• W2624340764 hasLocation W26243407644 @default.
• W2624340764 hasOpenAccess W2624340764 @default.

• next